These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 24947060)
1. Analysis of biodistribution of intracranially infused radiolabeled interleukin-13 receptor-targeted immunotoxin IL-13PE by SPECT/CT in an orthotopic mouse model of human glioma. Suzuki A; Leland P; Kobayashi H; Choyke PL; Jagoda EM; Inoue T; Joshi BH; Puri RK J Nucl Med; 2014 Aug; 55(8):1323-9. PubMed ID: 24947060 [TBL] [Abstract][Full Text] [Related]
2. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy. Lai EW; Joshi BH; Martiniova L; Dogra R; Fujisawa T; Leland P; de Krijger RR; Lubensky IA; Elkahloun AG; Morris JC; Puri RK; Pacak K J Clin Endocrinol Metab; 2009 Aug; 94(8):2952-7. PubMed ID: 19491224 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. Husain SR; Puri RK J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, Georgiou CJ; Cai Z; Alsaden N; Cho H; Behboudi M; Winnik MA; Rutka JT; Reilly RM Mol Pharm; 2023 Jan; 20(1):582-592. PubMed ID: 36516432 [TBL] [Abstract][Full Text] [Related]
6. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin. Kioi M; Seetharam S; Puri RK Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228 [TBL] [Abstract][Full Text] [Related]
7. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620 [TBL] [Abstract][Full Text] [Related]
8. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy. Shimamura T; Husain SR; Puri RK Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016 [TBL] [Abstract][Full Text] [Related]
9. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230 [TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250 [TBL] [Abstract][Full Text] [Related]
11. [Targeted therapy of malignant glioma by a chimeric fusion toxin composed of IL-13 and Pseudomonas exotoxin in vitro]. Zhang JJ; Weng RG; Liu J; Chen HP; Liu J; Ye H; Zheng WM Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):731-4. PubMed ID: 22781350 [TBL] [Abstract][Full Text] [Related]
12. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527 [TBL] [Abstract][Full Text] [Related]
13. Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer. Fujisawa T; Joshi BH; Puri RK J Transl Med; 2011 Apr; 9():37. PubMed ID: 21477288 [TBL] [Abstract][Full Text] [Related]
14. Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy. Kawakami K; Kioi M; Liu Q; Kawakami M; Puri RK J Immunother; 2005; 28(3):193-202. PubMed ID: 15838375 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy. Kawakami M; Kawakami K; Puri RK J Neurooncol; 2003 Oct; 65(1):15-25. PubMed ID: 14649882 [TBL] [Abstract][Full Text] [Related]
16. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma. Mintz A; Gibo DM; Madhankumar AB; Debinski W J Neurooncol; 2003; 64(1-2):117-23. PubMed ID: 12952292 [TBL] [Abstract][Full Text] [Related]